Mrv1909 12271913572D 18 19 0 0 0 0 999 V2000 2.7956 -0.1062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7094 0.7142 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9024 0.8857 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.4899 0.1712 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.0419 -0.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.3504 1.4988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6830 0.3428 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.5967 1.1633 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -2.7253 -0.8033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1123 -0.2513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3277 -0.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7146 0.0457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0699 -0.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5118 -1.6002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5100 -0.5484 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5100 -0.5187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0774 -0.5431 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.3149 1.6002 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 1 5 2 0 0 0 0 7 8 1 0 0 0 0 6 8 1 0 0 0 0 3 6 1 0 0 0 0 4 7 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 9 14 2 0 0 0 0 9 15 1 0 0 0 0 7 13 1 6 0 0 0 1 16 1 0 0 0 0 4 17 1 1 0 0 0 3 18 1 1 0 0 0 M END > DB03353 > drugbank > [H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])N=C(N)N2 > InChI=1S/C10H17N3O2S/c11-10-12-6-5-16-7(9(6)13-10)3-1-2-4-8(14)15/h6-7,9H,1-5H2,(H,14,15)(H3,11,12,13)/t6-,7-,9-/m0/s1 > WWVANQJRLPIHNS-ZKWXMUAHSA-N > C10H17N3O2S > 243.326 > 243.104147493 > 5 > 33 > 0.0031157447984472546 > 25.527550368524196 > 1 > 3 > 0 > 0 > 5-[(3aS,4S,6aR)-2-amino-1H,3aH,4H,6H,6aH-thieno[3,4-d]imidazol-4-yl]pentanoic acid > -1.145045947860176 > 0 > 0 > 2 > 0 > 4.061157863347519 > 10.85592882402283 > 87.71 > 62.2301 > 5 > 1 > N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl]cyclopentanecarboxamide > 0 > DB03353 > EXPT01870 > experimental; investigational > 2-Iminobiotin > Guanidinobiotin; Hexahydro-2-imino-1h-thieno(3,4-d)imidazole-4-pentanoic acid $$$$